SLE患者外周血调节性T细胞与IL-10、TGF-β1的检测(3)
 |
| 第1页 |
参见附件(253KB，3页)。
[4]Sarween N, Chodos A, Raykundalia C, et al. CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion[J]. J Immunol， 2004 ,173(5):2942-2951.
[5]Balandina A, Lecart S, Dartevelle P, et al. Functional defect of regulatory CD4+CD25+T cells in the thymus of patients with autoimmune myasthenia gravis [J]. Blood，2005,105(2):735-741.
[6]Richaud PY, Alcocer VJ, Llorente L. High levels of TH2 cytokine gene expression in systemic lupus erythematosus [J]. Rev Invest Clin,1995，47(4):267-269.
[7]Maloy KJ, Salaun L, Cahill R,et al. CD4+CD25+T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms[J]. J Exp Med, 2003,197:111-119.
[8] Masaki H, Cherry IK, Masanori N, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigen in vivo[J]. J Immunol，2001，166 (9):3789-3796.
[9]Yamagiwa S, Gray J, Hashimoto S, et al. A role for TGF-β in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood [J]. J Immunol，2001,166 (12):728-729.
[10] Feng Ning Zhan, Wu Hongfei,Wu Jun,et al. Immunology mechanism of CD4+CD25+ T regulatory cells acting on effect or T Cells[J]. Journal of Nanjing Medical University,2004,18(4):178-182.
(收稿日期：2007-07-20)
“本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文”
您现在查看是摘要介绍页，详见PDF附件(253KB，3页)。